NATIONAL Biocon eying global market for its product 'Insugen' Biotech major Biocon would take its latest product, bio-insulin 'Insugen' to global markets positioning it as a "very important drug from India", its chairman and managing director Kiran Mazumdar-Shaw said today (Nov 14, 2004).
Prasar Bharati kicks off Rs 500 cr DTH venture After a long wait, Public broadcaster Prasar Bharati has finally kicked off its Rs 500 crore DTH venture, roping in around two lakh subscribers to begin with.
Competitiveness will decide India's future: Kalam President A P J Abdul Kalam today (Nov 14, 2004) said competitiveness was the single factor that would decide India's transformation to a developed nation.
INTERNATIONAL Caparo group acquires five European steel companies Lord Swraj Paul's Caparo group today (Nov 14, 2004) announced acquisition of five European steel companies with a combined annual sales turnover of approximately 135 million pounds (Rs 1090 crore) for an undisclosed sum.
